Clinical trial
Impact of Full Correction of Post-transplant Anemia on the Cardiovascular System and Quality of Life in Renal Transplant Recipients Receiving Erythropoietin Stimulating Agents: a Prospective Randomized Controlled Trial.
NCT03861637 is registered in ClinicalTrials.gov with Hamid Al-Essa Organ Transplant Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of Full Correction of Post-transplant Anemia on the Cardiovascular System and Quality of Life in Renal Transplant Recipients Receiving Erythropoietin Stimulating Agents: a Prospective Randomized Controlled Trial.
- Lead sponsor
- Hamid Al-Essa Organ Transplant Center
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 20, 2015
- Completion date
- December 20, 2018
- Enrollment
- 280 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.